BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jabbar A, Ingoe L, Pearce S, Zaman A, Razvi S. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial. Trials 2015;16:115. [PMID: 25872532 DOI: 10.1186/s13063-015-0621-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang K, Wang W, Zhang K, Gao J, Liu Y, Zheng J, Li P, Tang Y. Prognostic value of free triiodothyronine and N-terminal pro-B-type natriuretic peptide for patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study. Ann Transl Med 2021;9:294. [PMID: 33708921 DOI: 10.21037/atm-20-5541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lamprou V, Varvarousis D, Polytarchou K, Varvarousi G, Xanthos T. The role of thyroid hormones in acute coronary syndromes: Prognostic value of alterations in thyroid hormones. Clin Cardiol 2017;40:528-33. [PMID: 28295435 DOI: 10.1002/clc.22689] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
3 Shi H, Kan Z, Liu Y, Li W, Peng M, Yang T. Efficacy and safety of thyroxine therapy on patients with heart failure and subclinical hypothyroidism: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e23947. [PMID: 33545971 DOI: 10.1097/MD.0000000000023947] [Reference Citation Analysis]
4 Gulzar R, Bukhari MH, Dar R, Sajjad H. Levels of serum thyroxine, triidothyronine and thyrotropin in patients with acute myocardial infarction. Pak J Med Sci 2018;34:950-4. [PMID: 30190759 DOI: 10.12669/pjms.344.14705] [Reference Citation Analysis]
5 Liu YS, Wei M, Wang L, Liu G, Ma GP, Ono K, Cao ZL, Yang M, Zheng MQ. The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention. BMC Endocr Disord 2021;21:43. [PMID: 33673843 DOI: 10.1186/s12902-021-00702-z] [Reference Citation Analysis]
6 Razvi S. Novel uses of thyroid hormones in cardiovascular conditions. Endocrine 2019;66:115-23. [PMID: 31617169 DOI: 10.1007/s12020-019-02050-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
7 Leng O, Razvi S. Treatment of subclinical hypothyroidism: assessing when treatment is likely to be beneficial. Expert Rev Endocrinol Metab 2021;16:73-86. [PMID: 32216473 DOI: 10.1080/17446651.2020.1738924] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A. The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect 2019;8:R76-90. [PMID: 30959486 DOI: 10.1530/EC-19-0096] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
9 Jabbar A, Ingoe L, Junejo S, Carey P, Addison C, Thomas H, Parikh JD, Austin D, Hollingsworth KG, Stocken DD, Pearce SHS, Greenwood JP, Zaman A, Razvi S. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial. JAMA 2020;324:249-58. [PMID: 32692386 DOI: 10.1001/jama.2020.9389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Stott DJ, Gussekloo J, Kearney PM, Rodondi N, Westendorp RG, Mooijaart S, Kean S, Quinn TJ, Sattar N, Hendry K, Du Puy R, Den Elzen WP, Poortvliet RK, Smit JW, Jukema JW, Dekkers OM, Blum M, Collet TH, McCarthy V, Hurley C, Byrne S, Browne J, Watt T, Bauer D, Ford I. Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST). BMC Endocr Disord 2017;17:6. [PMID: 28158982 DOI: 10.1186/s12902-017-0156-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
11 Cokkinos DV, Chryssanthopoulos S. Thyroid hormones and cardiac remodeling. Heart Fail Rev 2016;21:365-72. [PMID: 27138258 DOI: 10.1007/s10741-016-9554-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
12 Jabbar A, Ingoe L, Thomas H, Carey P, Junejo S, Addison C, Vernazza J, Austin D, Greenwood JP, Zaman A, Razvi S. Prevalence, predictors and outcomes of thyroid dysfunction in patients with acute myocardial infarction: the ThyrAMI-1 study. J Endocrinol Invest 2021;44:1209-18. [PMID: 32897534 DOI: 10.1007/s40618-020-01408-0] [Reference Citation Analysis]
13 Zhao JV, Schooling CM. Thyroid function and ischemic heart disease: a Mendelian randomization study. Sci Rep 2017;7:8515. [PMID: 28819171 DOI: 10.1038/s41598-017-07592-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
14 Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, Peeters R, Zaman A, Iervasi G. Thyroid Hormones and Cardiovascular Function and Diseases. J Am Coll Cardiol 2018;71:1781-96. [PMID: 29673469 DOI: 10.1016/j.jacc.2018.02.045] [Cited by in Crossref: 111] [Cited by in F6Publishing: 83] [Article Influence: 37.0] [Reference Citation Analysis]
15 Ragone MI, Bayley M, Colareda GA, Bonazzola P, Consolini AE. Cardioprotective Mechanisms of Hypothyroidism on Ischemia/Reperfusion in Rats and Effects of Carvedilol: Energetic Study. J Cardiovasc Pharmacol Ther 2020;25:72-85. [DOI: 10.1177/1074248419872957] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
16 Banu Rupani N, Alijanpour M, Babazadeh K, Hajian-Tilaki K, Moadabdoost F. Effect of levothyroxine on cardiac function in children with subclinical hypothyroidism: A quasi-experimental study. Caspian J Intern Med 2019;10:332-8. [PMID: 31558997 DOI: 10.22088/cjim.10.3.332] [Reference Citation Analysis]
17 Perrino C, Ferdinandy P, Bøtker HE, Brundel BJJM, Collins P, Davidson SM, den Ruijter HM, Engel FB, Gerdts E, Girao H, Gyöngyösi M, Hausenloy DJ, Lecour S, Madonna R, Marber M, Murphy E, Pesce M, Regitz-Zagrosek V, Sluijter JPG, Steffens S, Gollmann-Tepeköylü C, Van Laake LW, Van Linthout S, Schulz R, Ytrehus K. Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021;117:367-85. [PMID: 32484892 DOI: 10.1093/cvr/cvaa155] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
18 Manolis AA, Manolis TA, Melita H, Manolis AS. Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call? Trends in Cardiovascular Medicine 2020;30:57-69. [DOI: 10.1016/j.tcm.2019.02.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
19 Razvi S, Leng O, Jabbar A, Bano A, Ingoe L, Addison C, Thomas H, Carey P, Junejo S, Austin D, Greenwood JP, Zaman A. Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study. J Clin Endocrinol Metab 2020;105:dgz143. [PMID: 31769839 DOI: 10.1210/clinem/dgz143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Cao Q, Jiao Y, Yu T, Sun Z. Association between mild thyroid dysfunction and clinical outcome in acute coronary syndrome undergoing percutaneous coronary intervention. Cardiol J 2020;27:262-71. [PMID: 30234907 DOI: 10.5603/CJ.a2018.0097] [Reference Citation Analysis]
21 Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14:39-55. [PMID: 27811932 DOI: 10.1038/nrcardio.2016.174] [Cited by in Crossref: 197] [Cited by in F6Publishing: 186] [Article Influence: 32.8] [Reference Citation Analysis]
22 Tian XX, Zheng SF, Liu JE, Wu YY, Lin L, Chen HM, Li LW, Qin M, Wang ZX, Zhu Q, Lai WH, Zhong S. Free Triiodothyronine Connected With Metabolic Changes in Patients With Coronary Artery Disease by Interacting With Other Functional Indicators. Front Mol Biosci 2021;8:681955. [PMID: 34395522 DOI: 10.3389/fmolb.2021.681955] [Reference Citation Analysis]
23 Borisov DV, Gubaeva DN, Praskurnichiy EA. [Use of thyroid hormones in the treatment of cardiovascular diseases: literature review]. Probl Endokrinol (Mosk) 2020;66:6-14. [PMID: 33351333 DOI: 10.14341/probl12471] [Reference Citation Analysis]